Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 78Squamous Cell Carcinoma of Head and Neck 43Lung Neoplasms 35Oropharyngeal Neoplasms 22Urinary Bladder Neoplasms 20Head and Neck Neoplasms 18Nasopharyngeal Carcinoma 17Carcinoma 16Biliary Tract Neoplasms 15Small Cell Lung Carcinoma 14Neoplasm Metastasis 14Cholangiocarcinoma 14Parkinson Disease 4, Autosomal Dominant Lewy Body 13Esophageal Squamous Cell Carcinoma 13Colorectal Neoplasms 13Pancreatic Neoplasms 12Neoplasms 12Uterine Cervical Neoplasms 11Carcinoma, Squamous Cell 11Ovarian Neoplasms 10Mouth Neoplasms 9Laryngeal Neoplasms 9Gallbladder Neoplasms 8Endometrial Neoplasms 8Carcinoma, Transitional Cell 8Hypopharyngeal Neoplasms 7Esophageal Neoplasms 7Triple Negative Breast Neoplasms 6Stomach Neoplasms 6Mesothelioma, Malignant 6

Interventions

pembrolizumab 3lenvatinib 2Specimen Handling 2Nivolumab 2Cisplatin 2trastuzumab deruxtecan 1tivozanib 1liposomal doxorubicin 1entinostat 1dostarlimab 1bintrafusp alfa protein, human 1atezolizumab 1Therapeutic Touch 1Surveys and Questionnaires 1Radiotherapy 1Radiation 1Platinum 1Paclitaxel 1Nelfinavir 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Gemcitabine 1Doxorubicin 1Dehydroepiandrosterone 1CTLA-4 Antigen 1Bupropion 1Blood Specimen Collection 1Bevacizumab 1Axitinib 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vulvar Neoplasms × Cisplatin × 90 days × Clear all
NCT04169763 2026-05-20

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

M.D. Anderson Cancer Center

Phase 1 Recruiting
25 enrolled
Gynecologic

Vulvar Neoplasms

NCT04430699 2026-05-05

Cisplatin+Pembrolizumab+RT in Vulvar Cancer

Massachusetts General Hospital

Phase 2 Active not recruiting
24 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡